10 Stocks to Watch as the Rotation Builds
Mag 7 names are being sold — and that is good news for the rest of the market.
Trimming This Small-Cap Biotech on Strength as We Eye the Chart
Here’s what we’re seeing technically ahead of next week’s earnings.
The Bull Camp Is Shrinking. The Bear Camp Has Plenty of Empty Cabins.
Former bulls are gravitating to an unlikely destination — and it may not make investors happy campers.
Rocket Lab’s Chart Has Me Perplexed. Here’s My Next Move.
As Rocket Labs teases, I’m buying more, but lowering my expectations.
Rocket Lab Price Targets Are Falling, but We’re Making Another Trade Today
Our repair work continues on the $10,000 Portfolio.
The AI Trade Isn’t Over, but the Easy Gains Likely Are
The hot CPI report finally triggered the rotation. Breadth was the best in weeks as money moved toward the laggards.
Time to Make Some Moves as Things Get Ugly for the $10,000 Portfolio
Four buys, one sale and one exit as we fight back and right the ship.
VIDEO: Navigating Sticky Inflation Without Losing Sight of the AI Opportunity
Inflation is heading up again. Here’s what investors should focus on next.
Will a Hot CPI Report Widen the Gap in This Two-Tier Market?
Bonds are improving, but the stocks that should benefit aren’t responding.
Amid the Biotech Madness, I Spotted an Opening in a Promising Small-Cap
Hedge funds dumped genomics plays like this one last week … but it was just as it announced a new AstraZeneca-linked deal.